RHABDOID TUMOR OF THE KIDNEY
Clinical trials for RHABDOID TUMOR OF THE KIDNEY explained in plain language.
Never miss a new study
Get alerted when new RHABDOID TUMOR OF THE KIDNEY trials appear
Sign up with your email to follow new studies for RHABDOID TUMOR OF THE KIDNEY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy duo takes on rare childhood tumors
Disease control OngoingThis study tests whether combining two immunotherapy drugs, nivolumab and ipilimumab, can shrink or control rare INI1-negative cancers in children and young adults. These cancers have returned or not responded to standard treatments. The goal is to see if the drug combo helps the…
Matched conditions: RHABDOID TUMOR OF THE KIDNEY
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New combo therapy shows promise in advanced kidney cancer trial
Disease control OngoingThis phase 3 trial tests whether adding the targeted therapy cabozantinib to standard immunotherapy (nivolumab and ipilimumab) helps people with advanced kidney cancer live longer. About 1,175 adults with untreated, metastatic clear cell renal cell carcinoma are participating. Th…
Matched conditions: RHABDOID TUMOR OF THE KIDNEY
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 08, 2026 12:03 UTC